Company intelligence
Hevolution Foundation
Together We Thrive
About Hevolution Foundation
Founded on the belief that every person has the right to live a longer, healthier life, Hevolution Foundation is a global catalyst, partner, and convener on a mission to drive efforts to extend healthy human lifespan and understand aging processes. With a focus on aging as a treatable process, Hevolution Foundation aims to increase the number of aging-related treatments on the market, compress the timeline of drug development, and increase accessibility to therapeutics that extend a healthy healthspan. A global non-profit organization headquartered in Riyadh with a North American hub, and an annual budget of up to $1 Billion, Hevolution Foundation is the second largest geroscience funder with plans to open offices in other international locations to support a cutting-edge, global ecosystem of talent to propel aging and geroscience research forward and achieve medical breakthroughs to help humanity live healthier, longer.
Verified activity
Signals from Hevolution Foundation
2 published signals
Research & Knowledge
Hevolution Foundation published a study in Nature showing that application of GLP-1R agonist semaglutide for 3 months improved physiological function, attenuated hallmarks of aging, modulated nutrient sensors, conserved genetic regulators, and increased NAD+ levels, sirtuin expression, and downregulated IGF-1 in aged mice.
Reported by Lorenz Mayr
Research & Knowledge
Hevolution Foundation published a paper in Cell Press introducing the Reproductive Resilience Hypothesis by Buck Institute professor Dr. Pankaj Kapahi and senior postdoc Dr. Parminder Singh, supported by the foundation.
Reported by Hevolution Foundation